Biomarkers of healthy ageing: Expectations and validation

Proceedings of the Nutrition Society

Volumn 73, Issue 3, 2014, Pages 422-429

  Martin Ruiz, Carmen ^a   Von Zglinicki, Thomas ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Biomarker validation; Biomarkers; Healthy ageing; Human ageing; Human subjects

Indexed keywords

BIOLOGICAL MARKER; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DNA; HISTONE H2AX;

AGE; AGING; BIRTH; CHRONIC DISEASE; CONFERENCE PAPER; DNA DAMAGE; EXPECTATION; HEALTHY AGING; HUMAN; LIFE EXPECTANCY; LIFE HISTORY; NONHUMAN; NUTRITION; PHYSICAL PERFORMANCE; PREDICTION; SENESCENCE; SENSITIVITY AND SPECIFICITY; SYMPOSIUM; TELOMERE HOMEOSTASIS; ADVERSE OUTCOME; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CHRONIC INFLAMMATION; COGNITIVE DEFECT; DEATH; DEGENERATIVE DISEASE; DISABILITY; GENOTYPE PHENOTYPE CORRELATION; GERONTOLOGY; HOSPITALIZATION; INSTITUTIONALIZATION; LIPIDOMICS; MENTAL HEALTH; METABOLOMICS; PSYCHOLOGICAL WELL BEING; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; AGED; ANIMAL; FRAIL ELDERLY; HEALTH; LONGEVITY;

ANIMALIA; MAMMALIA;

AGED; AGING; ANIMALS; BIOLOGICAL MARKERS; FRAIL ELDERLY; HEALTH; HUMANS; LONGEVITY;

EID: 84904548989     PISSN: 00296651     EISSN: 14752719     Source Type: Journal    
DOI: 10.1017/S0029665114000147     Document Type: Conference Paper

References (94)

1. Reff ME &Schneider EL (1982) Biological Markers of Aging. Washingtonó DC: US Department of Health and Human Sciences
2. Baker GT III &Sprott RL (1988) Biomarkers of aging. Exp Gerontol 23ó 223-239
3. Nakamura Eó Lane MAó Roth GS et al. (1994) Evaluating measures of hematology and blood chemistry in male rhesus monkeys as biomarkers of aging. Exp Gerontol 29ó 151-177
4. Butler RNó Sprott Ró Warner H et al. (2004) Biomarkers of aging: From primitive organisms to humans. J Gerontol A Biol Sci Med Sci 59ó B560-B567
5. Ingram DKó Nakamura Eó Smucny D et al. (2001) Strategy for identifying biomarkers of aging in long-lived species. Exp Gerontol 36ó 1025-1034
6. Sprott RL (2010) Biomarkers of aging and disease: Introduction and definitions. Exp Gerontol 45ó 2-4
7. Warner HR (2004) Current status of efforts to measure and modulate the biological rate of aging. J Gerontol A Biol Sci Med Sci 59ó 692-696
8. Finch CE &Kirkwood TBL (2000) Chanceó Developmentó and Aging. New Yorkó USA: Oxford University Press
9. Holloszy JO (2000) The biology of aging. Mayo Clin Proc 75ó Suppl.ó S3-S8
10. Salminen Aó Kauppinen A &Kaarniranta K (2012) Emerging role of NF-?B signaling in the induction of senescence-Associated secretory phenotype (SASP). Cell Signal 24ó 835-845
11. Freund Aó Orjalo AVó Desprez P-Y et al. (2010) Inflammatory networks during cellular senescence: Causes and consequences. Trends Mol Med 16ó 238-246
12. Hillege HLó Nitsch Dó Pfeffer MA et al. (2006) Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 113ó 671-678
13. Collerton Jó Davies Kó Jagger C et al. (2009) Health and disease in 85 year olds: Baseline findings from the Newcastle 85+ cohort study. BMJ 339ó b4904
14. Fries JF (1980) Agingó natural deathó and the compression of morbidity. N Engl J Med 303ó 130-135
15. Crimmins EM &Beltran-Sanchez H (2011) Mortality and morbidity trends: Is there compression of morbidity?. J Gerontol B Psychol Sci Soc Sci 66ó 75-86
16. Andersen SLó Sebastiani Pó Dworkis DA et al. (2012) Health span approximates life span among many supercentenarians: Compression of morbidity at the approximate limit of life span. J Gerontol A Biol Sci Med Sci 67ó 395-405
17. Martin-Ruiz Có Jagger Có Kingston A et al. (2011) Assessment of a large panel of candidate biomarkers of ageing in the Newcastle 85+ study. Mech Ageing Dev 132ó 496-502
18. Fried LPó Tangen CMó Walston J et al. (2001) Frailty in older adults: Evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56ó M146-M156
19. Rockwood K &Mitnitski A (2007) Frailty in relation to the accumulation of deficits. J Gerontol A Biol Sci Med Sci 62ó 722-727
20. Searle SDó Mitnitski Aó Gahbauer EA et al. (2008) A standard procedure for creating a frailty index. BMC Geriatr 8ó 24
21. Rockwood Kó Mitnitski Aó Song X et al. (2006) Long-Term risks of death and institutionalization of elderly people in relation to deficit accumulation at age 70. J Am Geriatr Soc 54ó 975-979
22. Collerton Jó Martin-Ruiz Có Davies K et al. (2012) Frailty and the role of inflammationó immunosenescence and cellular ageing in the very old: Cross-sectional findings from the Newcastle 85+ Study. Mech Ageing Dev 133ó 456-466
23. Wills AKó Lawlor DAó Matthews FE et al. (2011) Life course trajectories of systolic blood pressure using longitudinal data from eight UK cohorts. PLoS Med 8ó e1000440
24. Borghi Có Dormi Aó LItalien G et al. (2003) The relationship between systolic blood pressure and cardiovascular risk - results of the Brisighella Heart Study. J Clin Hypertens (Greenwich) 5ó 47-52
25. Paultre F &Mosca L (2006) The relation of blood pressure to coronary heart mortality in Different age groups varies by ethnicity. Am J Hypertens 19ó 179-183
26. Kannel WBó Gordon T &Schwartz MJ (1971) Systolic versus diastolic blood pressure and risk of coronary heart disease: The Framingham study. Am J Cardiol 27ó 335-346
27. Euser SMó van Bemmel Tó Schram MT et al. (2009) The effect of age on the association between blood pressure and cognitive function later in life. J Am Geriatr Soc 57ó 1232-1237
28. Sabayan Bó van Vliet Pó de Ruijter W et al. (2013) High blood pressureó physical and cognitive functionó and risk of stroke in the oldest old: The Leiden 85-plus study. Stroke 44ó 15-20
29. Sabayan Bó Oleksik AMó Maier AB et al. (2012) High blood pressure and resilience to physical and cognitive decline in the oldest old: The Leiden 85-plus Study. J Am Geriatr Soc 60ó 2014-2019
30. Poortvliet RKó de Ruijter Wó de Craen AJ et al. (2013) Blood pressure trends and mortality: The Leiden 85-plus Study. J Hypertens 31ó 63-70
31. Blom JWó de Ruijter Wó Witteman JC et al. (2013) Changing prediction of mortality by systolic blood pressure with increasing age: The Rotterdam study. Age (Dordr) 35ó 431-438
32. von Zglinicki T &Martin-Ruiz CM (2005) Telomeres as biomarkers for ageing and age-related diseases. Curr Mol Med 5ó 197-203
33. von Zglinicki Tó Serra Vó Lorenz M et al. (2000) Short telomeres in patients with vascular dementia: An indicator of low antioxidative capacity and a possible risk factor?. Lab Invest 80ó 1739-1747
34. Cawthon RMó Smith KRó OBrien E et al. (2003) Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 361ó 393-395
35. Hoffmann J &Spyridopoulos I (2011) Telomere length in cardiovascular disease: New challenges in measuring this marker of cardiovascular aging. Future Cardiol 7ó 789-803
36. Mather KAó Jorm AFó Parslow RA et al. (2011) Is telomere length a biomarker of aging?. A review. J Gerontol A Biol Sci Med Sci 66ó 202-213
37. von Zglinicki T (2012) Will your telomeres tell your future?. BMJ 344ó e1727
38. Martin-Ruiz CMó Gussekloo Jó van Heemst D et al. (2005) Telomere length in white blood cells is not associated with morbidity or mortality in the oldest old: A populationbased study. Aging Cell 4ó 287-290
39. Gerstorf Dó Ram Nó Hoppmann C et al. (2011) Cohort differences in cognitive aging and terminal decline in the Seattle Longitudinal Study. Dev Psychol 47ó 1026-1041
40. Nybo Hó Petersen HCó Gaist D et al. (2003) Predictors of mortality in 2249 nonagenarians - The Danish 1905-Cohort Survey. J Am Geriatr Soc 51ó 1365-1373
41. Poortvliet RKó Blom JWó de Craen AJ et al. (2013) Low blood pressure predicts increased mortality in very old age even without heart failure: The Leiden 85-plus Study. Eur J Heart Fail 15ó 528-533
42. Birnie Kó Cooper Ró Martin RM et al. (2011) Childhood socioeconomic position and objectively measured physical capability levels in adulthood: A systematic review and meta-Analysis. PLoS ONE 6ó e15564
43. Seematter-Bagnoud L &Santos-Eggimann B (2006) Population-based cohorts of the 50s and over: A summary of worldwide previous and ongoing studies for research on health in ageing. Eur J Ageing 3ó 41-59
44. Wadsworth Mó Kuh Dó Richards M et al. (2006) Cohort Profile: The 1946 National Birth Cohort (MRC National Survey of Health and Development). Int J Epidemiol 35ó 49-54
45. Gow AJó Johnson Wó Pattie A et al. (2008) Mental ability in childhood and cognitive aging. Gerontology 54ó 177-186
46. Deary IJó Gow AJó Taylor MD et al. (2007) The Lothian Birth Cohort 1936: A study to examine influences on cognitive ageing from age 11 to age 70 and beyond. BMC Geriatr 7ó 28
47. Stenholm Só Harkanen Tó Sainio P et al. (2012) Long-Term changes in handgrip strength in men and women - Accounting the effect of right censoring due to death. J Gerontol A Biol Sci Med Sci 67ó 1068-1074
48. Stenholm Só Tiainen Kó Rantanen T et al. (2012) Long-Term determinants of muscle strength decline: Prospective evidence from the 22-year mini-Finland follow-up survey. J Am Geriatr Soc 60ó 77-85
49. Xue QLó Beamer BAó Chaves PH et al. (2010) Heterogeneity in rate of decline in gripó hipó and knee strength and the risk of all-cause mortality: The Womens Health and Aging Study II. J Am Geriatr Soc 58ó 2076-2084
50. Hart CLó Taylor MDó Smith GD et al. (2005) Childhood IQ and all-cause mortality before and after age 65: Prospective observational study linking the Scottish Mental Survey 1932 and the Midspan studies. Br J Health Psychol 10ó 153-165
51. Holsinger Tó Helms M &Plassman B (2007) Intelligence in early adulthood and life span up to 65 years later in male elderly twins. Age Ageing 36ó 286-291
52. Deary IJó Whiteman MCó Starr JM et al. (2004) The impact of childhood intelligence on later life: Following up the Scottish mental surveys of 1932 and 1947. J Pers Soc Psychol 86ó 130-147
53. Calvin CMó Deary IJó Fenton C et al. (2011) Intelligence in youth and all-cause-mortality: Systematic review with meta-Analysis. Int J Epidemiol 40ó 626-644
54. Andersen UOó Marott JL &Jensen GB (2011) Decreasing systolic blood pressure and declining mortality rates in an untreated population: Results from the Copenhagen City Heart Study. Eur J Cardiovasc Prev Rehabil 18ó 248-253
55. Arbeev KGó Ukraintseva SVó Akushevich I et al. (2011) Age trajectories of physiological indices in relation to healthy life course. Mech Ageing Dev 132ó 93-102
56. Andersen UO &Jensen GB (2010) Trends and determinant factors for population blood pressure with 25 years of follow-up: Results from the Copenhagen City Heart Study. Eur J Cardiovasc Prev Rehabil 17ó 655-659
57. Wang Hó Dwyer-Lindgren Ló Lofgren KT et al. (2012) Age-specific and sex-specific mortality in 187 countriesó 1970-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 380ó 2071-2094
58. Martin-Ruiz Có Dickinson HOó Keys B et al. (2006) Telomere length predicts poststroke mortalityó dementiaó and cognitive decline. Ann Neurol 60ó 174-180
59. Sebastiani Pó Solovieff Nó DeWan AT et al. (2012) Genetic signatures of exceptional longevity in humans. PLoS ONE 7ó e29848
60. Ruhaak LRó Koeleman CAó Uh HW et al. (2013) Targeted biomarker discovery by high throughput glycosylation profiling of human plasma alpha1-Antitrypsin and immunoglobulin A. PLoS ONE 8ó e73082
61. Mishur RJ &Rea SL (2012) Applications of mass spectrometry to metabolomics and metabonomics: Detection of biomarkers of aging and of age-related diseases. Mass Spectrom Rev 31ó 70-95
62. Hulbert AJ (2010) Metabolism and longevity: Is there a role for membrane fatty acids?. Integr Comp Biol 50ó 808-817
63. Jove Mó Naudi Aó Aledo JC et al. (2013) Plasma long-chain free fatty acids predict mammalian longevity. Sci Rep 3ó 3346
64. Hausman DBó Fischer JG &Johnson MA (2012) Proteinó lipidó and hematological biomarkers in centenarians: Definitionsó interpretation and relationships with health. Maturitas 71ó 205-212
65. Baker DJó Wijshake Tó Tchkonia T et al. (2011) Clearance of p16Ink4a-positive senescent cells delays ageingassociated disorders. Nature 479ó 232-236
66. Tchkonia Tó Zhu Yó van Deursen J et al. (2013) Cellular senescence and the senescent secretory phenotype: Therapeutic opportunities. J Clin Invest 123ó 966-972
67. Krishnamurthy Jó Torrice Có Ramsey MR et al. (2004) Ink4a/Arf expression is a biomarker of aging. J Clin Invest 114ó 1299-1307
68. Ressler Só Bartkova Jó Niederegger H et al. (2006) p16INK4A is a robust in vivo biomarker of cellular aging in human skin. Aging Cell 5ó 379-389
69. Rogakou EPó Boon Có Redon C et al. (1999) Megabase chromatin Domains involved in DNA double-strand breaks in vivo. J Cell Biol 146ó 905-916
70. Valdiglesias Vó Giunta Só Fenech M et al. (2013) gammaH2AX as a marker of DNA double strand breaks and genomic instability in human population studies. Mutat Res 753ó 24-40
71. Jacob KDó Noren Hooten Nó Trzeciak AR et al. (2013) Markers of oxidant stress that are clinically relevant in aging and age-related disease. Mech Ageing Dev 134ó 139-157
72. Mah LJó El-Osta A &Karagiannis TC (2010) GammaH2AX as a molecular marker of aging and disease. Epigenetics 5ó 129-136
73. Mayer PJó Lange CSó Bradley MO et al. (1989) Age-dependent decline in rejoining of X-ray-induced DNA double-strand breaks in normal human lymphocytes. Mutat Res 219ó 95-100
74. Singh NPó Danner DBó Tice RR et al. (1990) DNA damage and repair with age in individual human lymphocytes. Mutat Res 237ó 123-130
75. Garm Có Moreno-Villanueva Mó Burkle A et al. (2013) Age and gender effects on DNA strand break repair in peripheral blood mononuclear cells. Aging Cell 12ó 58-66
76. Ivashkevich Aó Redon CEó Nakamura AJ et al. (2012) Use of the gamma-H2AX assay to monitor DNA damage and repair in translational cancer research. Cancer Lett 327ó 123-133
77. Schurman SHó Dunn CAó Greaves R et al. (2012) Age-related disease association of endogenous gamma-H2AX foci in mononuclear cells derived from leukapheresis. PLoS ONE 7ó e45728
78. Passos JFó Nelson Gó Wang C et al. (2010) Feedback between p21 and reactive oxygen production is necessary for cell senescence. Mol Syst Biol 6ó 347
79. Wiley Ló Ashok Dó Martin-Ruiz CM et al. (2014) Reactive oxygen species production and mitochondrial dysfunction in white blood cells are not valid biomarkers of ageing in the very old. PLos ONE 9ó e91005
80. Rantanen Tó Harris Tó Leveille SG et al. (2000) Muscle strength and body mass index as long-Term predictors of mortality in initially healthy men. J Gerontol A Biol Sci Med Sci 55ó M168-M173
81. Rantanen Tó Avlund Kó Suominen H et al. (2002) Muscle strength as a predictor of onset of ADL dependence in people aged 75 years. Aging Clin Exp Res 14ó 10-15
82. Gale CRó Martyn CNó Cooper C et al. (2007) Grip strengthó body compositionó and mortality. Int J Epidemiol 36ó 228-235
83. Sasaki Hó Kasagi Fó Yamada M et al. (2007) Grip strength predicts cause-specific mortality in middle-Aged and elderly persons. Am J Med 120ó 337-342
84. Newman ABó Kupelian Vó Visser M et al. (2006) Strengthó but not muscle massó is associated with mortality in the healthó aging and body composition study cohort. J Gerontol A Biol Sci Med Sci 61ó 72-77
85. Bohannon RW (2008) Hand-grip dynamometry predicts future outcomes in aging adults. J Geriatr Phys Ther 31ó 3-10
86. Cooper Ró Kuh D &Hardy R (2010) Objectively measured physical capability levels and mortality: Systematic review and meta-Analysis. BMJ 341ó c4467
87. Shamliyan Tó Talley KMCó Ramakrishnan R et al. (2013) Association of frailty with survival: A systematic literature review. Ageing Res Rev 12ó 719-736
88. Wennie Huang W-Nó Perera Só VanSwearingen J et al. (2010) Performance measures predict onset of activity of daily living difficulty in community-dwelling older adults. J Am Geriatr Soc 58ó 844-852
89. Lin M-Ró Hwang H-Fó Hu M-H et al. (2004) Psychometric comparisons of the timed up and goó one-leg standó functional reachó and Tinetti balance measures in communitydwelling older people. J Am Geriatr Soc 52ó 1343-1348
90. Davis DHJó Rockwood MRHó Mitnitski AB et al. (2011) Impairments in mobility and balance in relation to frailty. Arch Gerontol Geriatr 53ó 79-83
91. Idland Gó Pettersen Ró Avlund K et al. (2013) Physical performance as long-Term predictor of onset of activities of daily living (ADL) disability: A 9-year longitudinal study among community-dwelling older women. Arch Gerontol Geriatr 56ó 501-506
92. Takata Yó Ansai Tó Soh I et al. (2012) Physical fitness and 65-year mortality in an 85-year-old community-dwelling population. Arch Gerontol Geriatr 54ó 28-33
93. Michikawa Tó Nishiwaki Yó Takebayashi T et al. (2009) One-leg standing test for elderly populations. J Orthop Sci 14ó 675-685
94. Taekema DGó Gussekloo Jó Westendorp RG et al. (2012) Predicting survival in oldest old people. Am J Med 125ó 1188-1194.e1